Current Overview on the Effects of COVID-19 Disease on Maternal and Neonatal Health; Narrative Review

The novel coronavirus infection (SARS-CoV-2 infection), which appeared in the Wuhan region of China in late 2019, spread rapidly in a short time. A few months later, it was ac-cepted as pandemic by the WHO (World Health Organization) and became an important threat to public health. The death rate in cases occurring in China was around 2%. Although it is thought that pregnancy is not a risk factor in the course of COVID-19 disease, it is often seen in which the cases were in the third trimester. It is striking that the maternal and neonatal implications of these infected cases during the late pregnancy period were quite good. Further studies examining more cases in the first and second trimesters, in order to determine long-term results and to clarify the risk of vertical transmission are needed.

COVID-19 Hastalığının Anne ve Yenidoğan Sağlığı Üzerine Etkilerine Güncel Bakış; Derleme

2019'un sonlarında Çin'in Wuhan bölgesinde ortaya çıkan yeni koronavirüs enfeksiyonu (SARS-CoV-2 enfeksiyonu) kısa sürede hızla yayıldı. Birkaç ay sonra, DSÖ (Dünya Sağlık Örgütü) tarafından salgın olarak kabul edildi ve halk sağlığı için önemli bir tehdit haline geldi. Çin'de meydana gelen vakalarda ölüm oranı %2 civarındaydı. COVID-19 hastalığı sırasında gebeliğin bir risk faktörü olmadığı düşünülse de, genellikle COVID-19'a rastalanan vakalar üçüncü trimesterde idi. Bu enfekte vakaların geç gebelik dönemindeki anne ve yenidoğan etkilerinin oldukça iyi olması dikkat çekicidir. Uzun dönem sonuçlarını belirlemek ve vertikal geçiş riskini açıklığa kavuşturmak için birinci ve ikinci trimesterde daha fazla vakayı inceleyen daha ileri çalışmalara ihtiyaç vardır.

Kaynakça

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727–33.

2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.

3. World Health Organization. Naming the coronavirus disease (COVID-2019) and the virus that causes it. Available at: https:// www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/ naming-the-coronavirus-disease-(covid-2019)-andthe- virus-that-causes-it. Accessed Feb 23, 2020.

4. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420–2.

5. T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. COVID-19 Rehberi. Available at: https://hsgm.saglik.gov.tr/tr/bulasici-hastaliklar/ 2019-n-cov.html. Accessed Sep 01, 2020.

6. McIntosh K. Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention. Available at: https://www.uptodate. com/contents/coronavirus-disease -2019-covid-19-epidemiologyvirology- and-prevention . Accessed Sep 01, 2020.

7. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 2020;222:415–26.

8. ACOG. Practice Advisory: Novel Coronavirus 2019 (COVID-19). Available at: https://www.acog.org/Clinical-Guidance-and-Publications/ Practice- Advisories/Practice-Advisory-Novel-Coronavirus2019? IsMobileSet=false. Accessed Mar 12, 2020.

9. RCOG. Coronavirus (COVID-19) _infection in pregnancy, 09/03/2020. Available at: https://www.rcog.org.uk/globalassets/ documents/gu_del_nes/coronaviruscovid-19- virusinfectioninpregnancy- 2020-03-09.pdf. Accesed Mar 12, 2020.

10. Alvarado MG, Schwartz DA. Zika Virus Infection in Pregnancy, Microcephaly, and Maternal and Fetal Health: What We Think, What We Know, and What We Think We Know. Arch Pathol Lab Med 2017;141:26–32.

11. Schwartz DA. Being Pregnant during the Kivu Ebola Virus Outbreak in DR Congo: The rVSV-ZEBOV Vaccine and Its Accessibility by Mothers and Infants during Humanitarian Crises and in Conflict Areas. Vaccines (Basel) 2020;8:38.

12. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395:809–15.

13. Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, et al. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis. AJR Am J Roentgenol 2020;215:127–32.

14. Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 2020;99:823–9.

15. Panahi L, Amiri M, Pouy S. Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review. Arch Acad Emerg Med 2020;8:e34.

16. Li N, Han L, Peng M, Lv Y, Ouyang Y, Liu K, et al. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study. Clin Infect Dis. 2020 Mar 30 [Epub ahead of print], doi: 10.1093/cid/ciaa352.

17. Mullins E, Evans D, Viner RM, O'Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol 2020;55:586–92.

18. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis 2020;20:559–64.

19. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020;9:51–60.

20. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004;191:292–7.

Kaynak Göster